InvestorsHub Logo
Followers 33
Posts 2835
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Thursday, 11/03/2022 1:49:28 PM

Thursday, November 03, 2022 1:49:28 PM

Post# of 265
ASH abstract

3325 Trial in Progress: A Phase 1 Umbrella Study of TCR-Engineered T Cells That Target HA-1 (TSC-100) and HA-2 (TSC-101) to Treat Residual Leukemia after Hematopoietic Cell Transplantation https://ash.confex.com/ash/2022/webprogram/Paper167707.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRX News